Medicinal Products

Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete

Name Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete
Marketing Authorisation Number HR-H-263764683
Active Substance abacavirum, lamivudinum
Pharmaceutical Form filmom obložena tableta
Strength 600 mg + 300 mg
Packaging [MA Number for Packaging] 10 tableta u blisteru, u kutiji  [HR-H-263764683-01]
10 tableta u perforiranom blisteru, u kutiji  [HR-H-263764683-02]
30 tableta u blisteru, u kutiji  [HR-H-263764683-03]
30 tableta u perforiranom blisteru, u kutiji  [HR-H-263764683-04]
90 tableta u blisteru, u kutiji  [HR-H-263764683-05]
90 tableta u perforiranom blisteru, u kutiji  [HR-H-263764683-06]
Manufacturer Pliva Hrvatska d.o.o., Zagreb, Republika Hrvatska;
Merckle GmbH, Ulm, Njemačka;
Teva Pharma B.V., Haarlem, Nizozemska
Marketing Authorisation Holder Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb
Marketing Authorisation Date 18.05.2016
MA Period of Validity 18.05.2021
Classification Number UP/I-530-09/15-01/18
Registration Number 381-12-01/70-16-08
Composition svaka fimom obložena tableta sadrži 600 mg abakavira i 300 mg lamivudina
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code J05AR02
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Prezentacija za zdravstvene radnike, verzija 3
Back